检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵露[1] 谢国丽[1] 杨秀芬[1] 尤冉 洪慧[1] 王艳玲[1]
机构地区:[1]首都医科大学附属北京友谊医院眼科,北京100050
出 处:《临床和实验医学杂志》2015年第21期1811-1813,共3页Journal of Clinical and Experimental Medicine
摘 要:目的:观察微创23G 玻璃体切割手术联合内界膜剥除术治疗玻璃体黄斑交界面疾病的临床疗效。方法回顾分析2015年1月至2015年6月在首都医科大学附属北京友谊医院眼科诊断为玻璃体视网膜界面疾病并接受了23G 微创玻璃体切割联合内界膜剥除术的26眼病例,术后随访3-6个月。使用频域相干光断层扫描(SD - OCT)观察术后黄斑形态变化恢复情况,并比较术前术后视力。结果术后 SD - OCT 提示玻璃体牵拉、黄斑前膜消失,黄斑水肿较术前减轻。11眼黄斑裂孔闭合,仅1眼未完全闭合。患者术前最佳矫正视力0.19±0.12,术后最后随访最佳矫正视力0.28±0.13。两者进行配对 t 检验,差异具有统计学意义( t =-6.153,P =0.000)。所有患者术中术后未发生严重并发症。结论对于玻璃体黄斑交界面疾病的患者,采用微创23G 玻璃体切割联合内界膜剥除术安全、有效,能明显改善术眼视力。Objective To observe the effects of 23G transconjunctival sutureless vitrectomy in the treatment of diseases of vitreo - maeular interface. Methods Twenty - six eyes of diagnosis of diseases of vitreo - maeular interface from January to June 2015 in Beijing Friendship Hos-pital,Capital Medical University were enrolled into the present study. All the eyes were treated with vitrectomy with internal limiting membrane peeling. The follow - up time was three to six months. Results Through the spectral domain coherent optical tomography,vitreous traction and macular epiretinal membrane disappeared and macular edema was lower than preoperation. Macular hole closure was achieved in 11 eyes and only one eye was not completely closed. The visual acuity was 0. 28 ± 0. 13 after operation,in comparison with 0. 19 ± 0. 12 preoperation. There were statistically significant differences( t = - 6. 153,P = 0. 000). There were no serious complications occurred in all patients. Conclusion The 23G transconjunctival sutureless vitrectomy with internal limiting membrane peeling for diseases of vitreo - maeular interface can obviously improve postoperative visual acuity,also the operation is safe and effective.
关 键 词:玻璃体黄斑交界面疾病 玻璃体切割术 内界膜剥除术
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.31